Endovascular embolization combined with anterior cervical corpectomy for treatment of cervical spinal dural arteriovenous fistula

The two main treatments for spinal dural arteriovenous fistula (SDAVF) include microsurgical occlusion or endovascular embolization (i.e., the latter alone has high recurrence rates). Here, we combined both strategies to treat/obliterate a cervical SDAVF more effectively. A 34-year-old male presente...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical neurology international 2024, Vol.15, p.341, Article 341
Hauptverfasser: Castillo-Rangel, Carlos, Gutierrez-Banos, Jose de J, Rodriguez-Pereira, Mauricio, Ordonez-Granja, Jaime, Ruvalcaba-Guerrero, Helen, Marin, Gerardo
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The two main treatments for spinal dural arteriovenous fistula (SDAVF) include microsurgical occlusion or endovascular embolization (i.e., the latter alone has high recurrence rates). Here, we combined both strategies to treat/obliterate a cervical SDAVF more effectively. A 34-year-old male presented with a marked decline in mental status attributed to an infratentorial subarachnoid hemorrhage. The left vertebral angiogram revealed a ruptured, low cervical SDAVF. He underwent successful occlusion of the spinal fistula utilizing super selective catheterization and endovascular embolization (i.e., utilizing Onyx-18 for the obliteration of target arteries). Due to significant SDAVF accompanying vessel recruitment/complex angioarchitecture, we additionally performed a C5 anterior corpectomy/fusion to afford direct access and complete surgical SDAVF occlusion. Three and 6 months later, repeated angiograms confirmed no recurrent or residual SDAVF. We successfully treated a low cervical SDAVF using a combination of endovascular embolization and direct surgical occlusion through an anterior C5 corpectomy with a fusion approach.
ISSN:2229-5097
2152-7806
DOI:10.25259/SNI_657_2024